05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
You’ve been at this Affordable Care Act reporting for years and are cruising on autopilot, right? R...
Read More >
Compliance officers and general counsel at corporations and businesses are told to surveil the lands...
Read More >
Bricker & Eckler's construction attorneys are proud to present "Top Gun," our premier Midwest constr...
Read More >
Opioid manufacturer Insys Therapeutics, which just last week agreed to pay $225 million to “settle ...
Read More >
The National Labor Relations Board (NLRB or Board) issued a decision on June 14, reversing nearly 40...
Read More >
On April 24, 2020, Governor Inslee announced a plan to allow current construction projects to be com...
Read More >